177 related articles for article (PubMed ID: 28230290)
1. A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.
Jafari SM; Panjehpour M; Aghaei M; Joshaghani HR; Enderami SE
J Cell Biochem; 2017 Sep; 118(9):2909-2920. PubMed ID: 28230290
[TBL] [Abstract][Full Text] [Related]
2. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
Mlejnek P; Dolezel P; Frydrych I
J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M; Zargar Balajam N
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28370734
[TBL] [Abstract][Full Text] [Related]
4. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
[TBL] [Abstract][Full Text] [Related]
5. A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines.
Joshaghani HR; Jafari SM; Aghaei M; Panjehpour M; Abedi H
J Cancer Res Ther; 2017; 13(1):107-112. PubMed ID: 28508842
[TBL] [Abstract][Full Text] [Related]
6. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
[TBL] [Abstract][Full Text] [Related]
7. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.
Coppi E; Cherchi F; Fusco I; Failli P; Vona A; Dettori I; Gaviano L; Lucarini E; Jacobson KA; Tosh DK; Salvemini D; Ghelardini C; Pedata F; Di Cesare Mannelli L; Pugliese AM
Pain; 2019 May; 160(5):1103-1118. PubMed ID: 31008816
[TBL] [Abstract][Full Text] [Related]
9. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A3 Receptor Mediates ERK1/2- and JNK-Dependent TNF-α Production in Toxoplasma gondii-Infected HTR8/SVneo Human Extravillous Trophoblast Cells.
Ye W; Sun J; Li C; Fan X; Gong F; Huang X; Deng M; Chu JQ
Korean J Parasitol; 2020 Aug; 58(4):393-402. PubMed ID: 32871633
[TBL] [Abstract][Full Text] [Related]
11. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
J Biol Chem; 2005 May; 280(20):19516-26. PubMed ID: 15774470
[TBL] [Abstract][Full Text] [Related]
12. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
Hussain A; Gharanei AM; Nagra AS; Maddock HL
Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol 3-O-D-glucuronide and resveratrol 4'-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest.
Polycarpou E; Meira LB; Carrington S; Tyrrell E; Modjtahedi H; Carew MA
Mol Nutr Food Res; 2013 Oct; 57(10):1708-17. PubMed ID: 23650147
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A
Cohen S; Barer F; Itzhak I; Silverman MH; Fishman P
J Immunol Res; 2018; 2018():2310970. PubMed ID: 29862305
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
16. Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells.
War SA; Kim B; Kumar U
Mol Cell Endocrinol; 2015 Sep; 413():129-44. PubMed ID: 26112183
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of the human A
Storme J; Cannaert A; Van Craenenbroeck K; Stove CP
Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells.
Di Sole F; Cerull R; Babich V; Casavola V; Helmle-Roth C; Burckhardt G
J Cell Physiol; 2008 Jul; 216(1):221-33. PubMed ID: 18286509
[TBL] [Abstract][Full Text] [Related]
19. A3 adenosine receptor agonist potentiates natural killer cell activity.
Harish A; Hohana G; Fishman P; Arnon O; Bar-Yehuda S
Int J Oncol; 2003 Oct; 23(4):1245-9. PubMed ID: 12964011
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
